Abstract
Extracellular matrix (ECM) provides a physical scaffold for cells but also provides specific molecular and spatial information that influences cell proliferation, differentiation and apoptosis. This review addresses the multiple roles of ECM in inflammatory responses, in particular in leukocyte extravasation at sites of inflammation, and the potential of exploiting such cell-ECM interactions to interfere with defined steps in the inflammatory process. In the course of an inflammation leukocytes not only have to penetrate the vascular endothelial cell monolayer, but also the underlying endothelial cell basement membrane and invade the interstitial matrix of the stroma to reach the site of inflammation. The endothelial cell basement membrane may directly influence leukocyte recruitment to the inflammed tissue by providing differential signals resulting from its spatial and molecular composition, or indirectly by its potential to bind and present cytokines or chemotactic factors. Proteases (in particular matrix metalloproteinases (MMP)) released at sites of inflammation selectively process ECM and cell surface molecules, which may result in the release of bioactive fragments that may function as chemoattractants for different leukocytes subsets or modulate the activity/ function of resident mesenchymal and immune cells. In addition, MMPs have been shown to process chemokines modulating their chemoattractant properties. To be able to mimic or inhibit some of the ECM functions or proteolytic events that occur during inflammation, through the use of specific protein fragments, would provide a means by which the inflammatory process could be manipulated, an area however that remains largely unexplored.
Keywords: Basement membrane, laminin, inflammation, extravasation
Current Pharmaceutical Design
Title: Multiple Roles of the Extracellular Matrix in Inflammation
Volume: 15 Issue: 12
Author(s): E. Korpos, C. Wu and L. Sorokin
Affiliation:
Keywords: Basement membrane, laminin, inflammation, extravasation
Abstract: Extracellular matrix (ECM) provides a physical scaffold for cells but also provides specific molecular and spatial information that influences cell proliferation, differentiation and apoptosis. This review addresses the multiple roles of ECM in inflammatory responses, in particular in leukocyte extravasation at sites of inflammation, and the potential of exploiting such cell-ECM interactions to interfere with defined steps in the inflammatory process. In the course of an inflammation leukocytes not only have to penetrate the vascular endothelial cell monolayer, but also the underlying endothelial cell basement membrane and invade the interstitial matrix of the stroma to reach the site of inflammation. The endothelial cell basement membrane may directly influence leukocyte recruitment to the inflammed tissue by providing differential signals resulting from its spatial and molecular composition, or indirectly by its potential to bind and present cytokines or chemotactic factors. Proteases (in particular matrix metalloproteinases (MMP)) released at sites of inflammation selectively process ECM and cell surface molecules, which may result in the release of bioactive fragments that may function as chemoattractants for different leukocytes subsets or modulate the activity/ function of resident mesenchymal and immune cells. In addition, MMPs have been shown to process chemokines modulating their chemoattractant properties. To be able to mimic or inhibit some of the ECM functions or proteolytic events that occur during inflammation, through the use of specific protein fragments, would provide a means by which the inflammatory process could be manipulated, an area however that remains largely unexplored.
Export Options
About this article
Cite this article as:
Korpos E., Wu C. and Sorokin L., Multiple Roles of the Extracellular Matrix in Inflammation, Current Pharmaceutical Design 2009; 15 (12) . https://dx.doi.org/10.2174/138161209787846685
DOI https://dx.doi.org/10.2174/138161209787846685 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Multidisciplinary Pharmaceutical Drug Design Strategies in the Progress of Drug Discovery"
The process of developing a drug is time- and money-consuming, but also fascinating. The development of numerous computational techniques, synthetic methodologies, formulation-based drug discovery, etc. has improved the drug discovery process. The process of developing new drugs is significantly hampered by drug-poor pharmacodynamics and pharmacokinetic problems. To address these challenges, ...read more
Advances in the Molecular Pathogenesis of Inflammatory Bowel Disease.
This thematic issue will emphasize the recent breakthroughs in the mechanisms of Inflammatory bowel disease (IBD) pathogenesis and devotes some understanding of both Crohn’s and ulcerative colitis. It is expected to include studies about cellular and genetic aspects, which help to precipitate the disease, and the immune system-gut microbiome relations ...read more
Blood-based biomarkers in large-scale screening for neurodegenerative diseases
Disease biomarkers are necessary tools that can be employed in several clinical context of use (COU), ranging from the (early) diagnosis, prognosis, and prediction, to monitoring of disease state and/or drug efficacy. Regarding neurodegenerative diseases, in particular Alzheimer’s disease (AD), a battery of well-validated biomarkers are available, such as cerebrospinal ...read more
Diabetes mellitus: advances in diagnosis and treatment driving by precision medicine
Diabetes mellitus (DM) is a chronic degenerative metabolic disease with ever increasing prevalence worldwide which is now an epidemic disease affecting 500 million people worldwide. Insufficient insulin secretion from pancreatic β cells unable to maintain blood glucose homeostasis is the main feature of this disease. Multifactorial and complex nature of ...read more

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Concurrence of Talaromycosis and Kaposi Sarcoma in an HIV-Infected Patient: A Case Report
Current HIV Research Cellular Membrane Microparticles: Potential Targets of Combinational Therapy for Vascular Disease
Current Vascular Pharmacology Genetics and Epigenetics Mechanism in the Pathogenesis of Behçet’s Disease
Current Rheumatology Reviews Cannabinoids and Neuro-Inflammation: Regulation of Brain Immune Response
Recent Patents on CNS Drug Discovery (Discontinued) Is Targeting microRNAs the Philosopher’s Stone for Vascular Disease?
Current Vascular Pharmacology Angiogenesis in Chronic Lymphocytic Leukemia
Current Angiogenesis (Discontinued) Acute Hemorrhagic Edema of Infancy: A Diagnostic Challenge for the General Pediatrician
Current Pediatric Reviews Efficacy of Rituximab on Refractory Organ Involvements in Granulomatosis with Polyangiitis: A Systematic Review of Case Reports
Current Rheumatology Reviews Angiogenesis as Risk Factor for Plaque Vulnerability
Current Pharmaceutical Design The Rationale and Development of New Drugs to Treat HIV Infection
Medicinal Chemistry The Importance of Reendothelialization After Arterial Injury
Current Pharmaceutical Design Etiopathogenesis, Classical Immunotherapy and Innovative Nanotherapeutics for Inflammatory Neurological Disorders
Current Nanoscience Imatinib Mesylate (Gleevec©): Targeted Therapy Against Cancer with Immune Properties
Endocrine, Metabolic & Immune Disorders - Drug Targets Histopathology of Connective Tissue Disease-Associated Pleuropulmonary Disease
Current Respiratory Medicine Reviews Soluble Adhesion Molecules in the Pathogenesis of Rheumatoid Arthritis
Current Pharmaceutical Design Targeting α7 Nicotinic Acetylcholine Receptor to Combat Inflammation in Cardio-Cerebral-Vascular Diseases
Current Drug Targets Transport Mechanisms at the Blood-Cerebrospinal-Fluid Barrier: Role of Megalin (LRP2)
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Transgenic Models in Allergic Responses
Current Drug Targets Studies on Novel Pyridine and 2-pyridone Derivatives of N-arylpiperazine as α-adrenoceptor Ligands
Medicinal Chemistry Rheumatoid Nodules and Lung
Current Respiratory Medicine Reviews